Stock market news

Novartis

Novartis' IFRS net income for 2022 was $6.955 billion, down 19.7% from $8.661 billion in the previous year. Revenue decreased by 2.1% to $50.545 billion from $51.626 billion a year earlier.

Nebius Group

IT company Yandex is developing a Russian version of the ChatGPT neural network. Training will begin soon, and the first integrations of YaLM 2.0 with Search, Alice, Mail and other services may take place before the end of the year. Company is one of the first in the world to implement such a neural network. Microsoft has similar plans with ChatGPT for its s...

Positive Technologies Group

Positive Technologies closed its offices in Britain and the Czech Republic. As Boris Simis, deputy general director of the company, explained in 2017, Positive Technologies was recruiting research staff in its London office and also opened a development center in the Czech Republic, where many technical universities are located. Now the company only has a re...

Mondelēz International

Mondelēz International's GAAP net income for 2022 was $2.726 billion, down 36.8% from $4.314 billion in the previous year. Revenue increased by 9.7% to $31.496 billion from $28.72 billion a year earlier.

Advanced Micro Devices

AMD's GAAP net income for 2022 was $1.32 billion, down 2.4 times from $3.162 billion the previous year. Revenue increased 43.6% to $23.601 billion from $16.434 billion a year earlier.

Electronic Arts

Electronic Arts' GAAP net income for 9 months of fiscal year 2023 was $814 million, up 44.3% from $564 million in the previous year. Revenue rose 7.5% to $5.552 billion from $5.166 billion a year earlier.

Micro Focus International

Open Text completed its acquisition of Micro Focus International for $5.8 billion, or 532 pence per share.

Amgen

Amgen's GAAP net income for 2022 was $6.552 billion, up 11.2% from $5.893 billion in previous year. Revenues increased 1.3% to $26.323 billion from $25.979 billion a year earlier.

Unipro

Generation by Unipro's power plants in 2022 was 53.96 billion kWh, 19.3% more than in 2021. Useful output increased by 13.01% to 13.653 billion kWh.

Chembio Diagnostics

Biosynex is buying Chembio for $17.2 million, or $0.45 per share. Closing of deal is planned in the 1st quarter of the current year.